How to switch an adult patient with type 2 diabetes from Novo Mix (insulin aspart protamine/insulin aspart) to insulin aspart and insulin glargine as an inpatient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from NovoMix to Insulin Aspart and Glargine in Hospitalized Patients

Calculate Total Daily Dose from Current NovoMix Regimen

Start by determining the patient's current total daily insulin dose from their NovoMix regimen, as this forms the foundation for the conversion. 1

  • Add up all NovoMix doses administered in 24 hours to get the total daily dose (TDD)
  • For hospitalized patients who are insulin-naive or on low-dose insulin at home, use 0.3-0.5 units/kg as TDD, with half as basal insulin 2
  • For patients on high-dose home insulin (≥0.6 units/kg/day), reduce the TDD by 20% upon hospitalization to prevent hypoglycemia 2, 1

Split the Total Daily Dose: 50% Basal, 50% Bolus

Divide the calculated TDD using a 50:50 split between basal glargine and prandial aspart, as this ratio is specifically recommended for hospitalized patients requiring basal-bolus therapy. 1

  • Give 50% of TDD as insulin glargine once daily (typically in the evening) 1, 2
  • Divide the remaining 50% equally among three meals as insulin aspart 1, 2
  • Example: If TDD = 60 units, give glargine 30 units once daily + aspart 10 units before each meal 2

Adjust for High-Risk Populations

For elderly patients (>65 years), those with renal failure, or poor oral intake, use lower starting doses of 0.1-0.25 units/kg/day to prevent hypoglycemia. 1, 2

  • Reduce the calculated TDD by 20-50% in these high-risk groups 1, 2
  • Monitor more frequently (every 4-6 hours if poor oral intake) 1

Titration Protocol After Conversion

Adjust basal glargine every 3 days based on fasting glucose patterns, targeting 80-130 mg/dL. 2, 1

  • If fasting glucose 140-179 mg/dL: increase glargine by 2 units every 3 days 2
  • If fasting glucose ≥180 mg/dL: increase glargine by 4 units every 3 days 2
  • Adjust prandial aspart by 1-2 units every 3 days based on 2-hour postprandial glucose, targeting <180 mg/dL 1

Add Correction Insulin

Implement a correction insulin protocol using aspart for premeal glucose >180 mg/dL, separate from scheduled doses. 1

  • Use simplified sliding scale: 2 units aspart for glucose >250 mg/dL, 4 units for glucose >350 mg/dL 1
  • Never rely on correction insulin alone—scheduled basal-bolus therapy must remain the foundation 1

Critical Threshold Warning

When basal glargine exceeds 0.5 units/kg/day without achieving glycemic targets, intensify prandial insulin rather than continuing to escalate basal insulin alone, as this leads to "overbasalization" with increased hypoglycemia risk. 2, 1

  • Clinical signals of overbasalization include: basal dose >0.5 units/kg/day, bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia episodes, and high glucose variability 2

Special Considerations for Poor Oral Intake

If the patient develops poor oral intake after conversion, immediately reduce TDD to 0.1-0.15 units/kg/day given primarily as basal insulin, with correctional aspart only for glucose >180 mg/dL. 1

  • Continue basal insulin coverage even with minimal intake, rather than stopping all insulin 1
  • Check glucose every 4-6 hours instead of premeal 1

Avoid Common Pitfalls

  • Never use sliding scale insulin as monotherapy—this approach is explicitly condemned by all major guidelines and leads to dangerous glucose fluctuations 1
  • Never give rapid-acting insulin at bedtime—this increases nocturnal hypoglycemia risk 1
  • Never continue premixed insulin (NovoMix) in hospitalized patients—randomized trials show significantly increased hypoglycemia rates compared to basal-bolus regimens 1
  • If hypoglycemia occurs, reduce the relevant insulin component by 10-20% immediately 2, 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the weight-based management for an 80 kg female regarding Basal (long-acting) insulin and bolus (short-acting, 'bonus') insulin?
What is the most appropriate plan for a 78-year-old male with type 2 diabetes mellitus (T2DM) and impaired renal function, who is being discharged home after a total knee replacement, to manage his blood glucose levels?
What is the best approach for managing hyperglycemia in an adult patient with type 2 diabetes, currently on 24 units of Basaglar (insulin glargine) and 4 units of Novolog (insulin aspart) three times a day before meals, with consistently elevated blood sugar levels?
How to convert a patient's insulin regimen from basal-bolus (basal: e.g. glargine, bolus: e.g. aspart) to a mixed insulin regimen?
How to manage a patient with recurrent ketosis and impaired glucose control on their current insulin regimen?
What is the best course of treatment for a patient with end-stage renal disease (ESRD) experiencing neck muscle spasm after dialysis?
What are the uses of Acetylcysteine (N-acetylcysteine) effervescent tablets?
What is the typical recovery time for a muscular strain in a healthy adult with no significant past medical history?
How do PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) inhibitors affect kidney function in patients with pre-existing kidney disease?
What is causing muscle spasms in the neck and leg of a patient after undergoing dialysis?
What are the potential nail disorders associated with isotretinoin (13-cis-retinoic acid) treatment and how can they be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.